Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Curex
WARNING LETTER
•Curex•August 31, 2025

Curex – FDA Warning Letter, Aug 31, 2025

Record Details

The FDA issued a warning letter to Curex, located at 777 Brickell Ave, Miami, FL, on September 9, 2025, following a review of their website in August 2025. The review revealed that Curex offers compounded drug products, specifically semaglutide and tirzepatide, with claims that are deemed false or misleading under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act (FDCA). These claims suggest that the compounded products are equivalent to FDA-approved drugs, which they are not, resulting in the products being misbranded and their introduction into interstate commerce violating section 301(a) of the FDCA.

The FDA requires Curex to take immediate corrective actions, including ceasing misleading advertising and ensuring compliance with federal regulations. Curex must provide a written response within 15 working days detailing the steps taken to address the violations and prevent future occurrences. Failure to comply may lead to legal actions, such as product seizure or injunctions. The letter also advises that if Curex believes their products are not in violation, they should provide supporting information for consideration. Correspondence should be directed to the Office of Compounding Quality and Compliance.

Company
Curex
Inspection date
August 31, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • George Tidmarsh (Director)
View Company Profile

ID · 1a06762d-9cd1-4ebd-b344-1c2e4b2928e4

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 352(bb)21 U.S.C. 331(c)21 U.S.C. 321(p)FD&C Act 502(a)FD&C Act 301(a)FD&C Act 201(g)FD&C Act 502(b)21.U.S.C. 331(a)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Other documents for Curex
  • WARNING_LETTER - 2025-08-01August 1, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Curex
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.